Cochrane Abstracts
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Optimisation of Chemotherapy and Radiotherapy for Untreated Hodgkin Lymphoma Patients With Respect to Second Malignant Neoplasms, Overall and Progression‐free Survival: Individual Participant Data Analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437455/all/Optimisation_of_chemotherapy_and_radiotherapy_for_untreated_Hodgkin_lymphoma_patients_with_respect_to_second_malignant_neoplasms__overall_and_progression‐free_survival:_individual_participant_data_analysis. Accessed 02 December 2023.
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437455/all/Optimisation_of_chemotherapy_and_radiotherapy_for_untreated_Hodgkin_lymphoma_patients_with_respect_to_second_malignant_neoplasms__overall_and_progression‐free_survival:_individual_participant_data_analysis. Accessed December 2, 2023.
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437455/all/Optimisation_of_chemotherapy_and_radiotherapy_for_untreated_Hodgkin_lymphoma_patients_with_respect_to_second_malignant_neoplasms__overall_and_progression‐free_survival:_individual_participant_data_analysis
Optimisation of Chemotherapy and Radiotherapy for Untreated Hodgkin Lymphoma Patients With Respect to Second Malignant Neoplasms, Overall and Progression‐free Survival: Individual Participant Data Analysis [Internet]. In: Cochrane Abstracts. [cited 2023 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437455/all/Optimisation_of_chemotherapy_and_radiotherapy_for_untreated_Hodgkin_lymphoma_patients_with_respect_to_second_malignant_neoplasms__overall_and_progression‐free_survival:_individual_participant_data_analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis
ID - 437455
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437455/all/Optimisation_of_chemotherapy_and_radiotherapy_for_untreated_Hodgkin_lymphoma_patients_with_respect_to_second_malignant_neoplasms__overall_and_progression‐free_survival:_individual_participant_data_analysis
DB - Evidence Central
DP - Unbound Medicine
ER -
